Real-Life Efficacy and Safety of BRAF Inhibitors in Erdheim-Chester Disease. - Pegoraro F; Peyronel F; Papo M; Sutera R; Catamerò F; Poeta F; Razanamahery J; Ledoult E; Le Scornet T; de Menthon M; Riviere E; Sieni E; et al. (American journal of hematology, 2026)